MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The Impact of short in-patient rehabilitation courses for people with Parkinson´s disease

S. Kinos, K. Martikainen, T. Vahlberg, R. Marttila (Turku, Finland)

Meeting: 2018 International Congress

Abstract Number: 909

Keywords: Parkin, Rehabilitation

Session Information

Date: Sunday, October 7, 2018

Session Title: Other

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To find out whether a 10 to 14 days group-based multidisciplinary in-patient rehabilitation course for patients with Parkinson´s disease has any long-term effect on functioning, disability, mood and ability to work.

Background: In-patient rehabilitation courses require economical resources from national social insurance in Finland, as well as time resources from patients. More information is needed about their impact and benefits. However, measurement of long-term effects of rehabilitation in degenerative diseases as Parkinson’s is challenging.

Methods: During a period of three years, all applicants (N=1535) for Parkinson´s rehabilitation courses in Finland were sent a questionnaire to fill in and return. 1007 patients agreed to participate in the study. A follow-up questionnaire was send after six months to those who completed the first one, and 785 returned it (46% female, 54% male; mean age 65.9 yrs; on av. 4.8 yrs from diagnosis). The questionnaires included e.g. UPDRS II (Unified Parkinson’s disease rating scale part II) and GDS (Geriatric depression scale) scales. The results were analyzed with appropriate statistical methods in two main groups: 1. Patients who had attended a course (research group) and 2. Patients who were still waiting for a suitable course after six months (control group).

Results: The baseline UPDRS II sum mean (SD) was 12.3 (6.7) and follow-up 12.9 (7.1) in the research group and 15.3 (7.5) and 15.6 (7.7) in the control group, GDS sum 4.7 (3.7) -4.8 (3.9) and 5.5 (4.0) – 5.3 (4.0), respectively. No statistically significant difference in changes in UPDRS II 0.6 (3.9) vs. 0.3 (4.3) or GDS 0.06 (2.7) vs. -0.16 (2.8) between these two groups was found, in 6 months follow-up. At baseline 57 of 299 (19%) participants who were <65 years old were still working. Neither was any statistically significant difference found, when comparing changes in employment between the two groups (percentage working: research group 9.1 % -> 6.5 %, control group 4.6 % -> 2.9 %),

Conclusions: Short in-patient courses may have beneficial short-term effects, but scales like UPDRS and GDS do not confirm long-term impact on functioning, disability or mood. Long-term professional support, in close connection with everyday life at home and work, may give more durable results. However, a further study with qualitative methods might bring up deeper aspects and significance of individual in-patient rehabilitation experience.

To cite this abstract in AMA style:

S. Kinos, K. Martikainen, T. Vahlberg, R. Marttila. The Impact of short in-patient rehabilitation courses for people with Parkinson´s disease [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/the-impact-of-short-in-patient-rehabilitation-courses-for-people-with-parkinsons-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-impact-of-short-in-patient-rehabilitation-courses-for-people-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley